Stockscreener 앱 받기
572.37
0.94%
-5.07
전일 마감가:
$577.44
열려 있는:
$577.44
하루 거래량:
189.88K
Relative Volume:
0.37
시가총액:
$45.43B
수익:
$4.30B
순이익/손실:
$1.06B
주가수익비율:
43.76
EPS:
13.0798
순현금흐름:
$1.04B
1주 성능:
+1.80%
1개월 성능:
-5.98%
6개월 성능:
-8.81%
1년 성능:
+50.93%
1일 변동 폭
$569.72
$579.93
1주일 범위
$548.56
$580.90
52주 변동 폭
$356.14
$769.98
아이덱스 래버러토리스 Stock (IDXX) Company Profile
명칭
Idexx Laboratories Inc
전화
(207) 556-0300
주소
ONE IDEXX DRIVE, WESTBROOK, ME
Compare IDXX vs TMO, DHR, A, WAT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IDXX
Idexx Laboratories Inc
|
571.98 | 45.86B | 4.30B | 1.06B | 1.04B | 13.08 |
TMO
Thermo Fisher Scientific Inc
|
484.28 | 181.35B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
190.02 | 135.96B | 24.57B | 3.60B | 5.26B | 5.051 |
A
Agilent Technologies Inc
|
113.66 | 32.45B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
302.63 | 29.83B | 3.17B | 642.63M | 516.49M | 10.77 |
아이덱스 래버러토리스 Stock (IDXX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-09 | 개시 | Barclays | Overweight |
| 2025-10-31 | 업그레이드 | Stifel | Hold → Buy |
| 2025-10-01 | 개시 | UBS | Neutral |
| 2025-08-05 | 재확인 | BTIG Research | Buy |
| 2025-07-01 | 개시 | Jefferies | Buy |
| 2024-12-02 | 개시 | Leerink Partners | Outperform |
| 2024-07-25 | 개시 | BTIG Research | Buy |
| 2024-01-30 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2023-12-07 | 개시 | Exane BNP Paribas | Outperform |
| 2023-12-04 | 업그레이드 | Cleveland Research | Neutral → Buy |
| 2023-08-02 | 다운그레이드 | Atlantic Equities | Overweight → Neutral |
| 2022-07-25 | 다운그레이드 | Stifel | Buy → Hold |
| 2022-07-21 | 업그레이드 | Goldman | Neutral → Buy |
| 2022-07-12 | 개시 | Piper Sandler | Overweight |
| 2022-05-05 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-02-08 | 개시 | Atlantic Equities | Overweight |
| 2021-11-18 | 개시 | Morgan Stanley | Overweight |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2021-07-12 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2021-02-17 | 개시 | Barclays | Overweight |
| 2019-09-09 | 개시 | Goldman | Neutral |
| 2019-05-23 | 개시 | Guggenheim | Buy |
| 2018-11-02 | 재확인 | BofA/Merrill | Buy |
| 2018-05-07 | 재확인 | Stifel | Buy |
| 2018-01-16 | 개시 | Piper Jaffray | Overweight |
| 2017-08-23 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2017-07-28 | 업그레이드 | CL King | Neutral → Buy |
| 2017-02-03 | 다운그레이드 | Feltl & Co. | Hold → Sell |
| 2016-09-29 | 재개 | BofA/Merrill | Neutral |
| 2016-08-16 | 재확인 | Stifel | Buy |
| 2016-08-03 | 업그레이드 | Northcoast | Sell → Neutral |
| 2016-07-20 | 재확인 | Canaccord Genuity | Buy |
| 2016-04-19 | 재확인 | Canaccord Genuity | Buy |
| 2016-04-01 | 개시 | CL King | Neutral |
| 2016-03-21 | 재확인 | Stifel | Buy |
| 2016-02-04 | 개시 | Credit Suisse | Outperform |
| 2015-10-29 | 재확인 | Stifel | Buy |
| 2015-08-28 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2015-08-13 | 재확인 | Stifel | Buy |
| 2015-07-23 | 재확인 | Canaccord Genuity | Buy |
모두보기
아이덱스 래버러토리스 주식(IDXX)의 최신 뉴스
William Blair Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating - Moomoo
IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch
IDEXX Laboratories, Inc. $IDXX Shares Sold by Rathbones Group PLC - MarketBeat
IDEXX Laboratories, Inc. (IDXX) Stock forecasts - Yahoo Finance UK
Why Idexx Laboratories (IDXX) is a Top Growth Stock for the Long-Term - Yahoo Finance
Rally Mode: Can IDEXX Laboratories Inc deliver alphaDip Buying & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
IDEXX Laboratories, Inc. (IDXX) Stock Forecasts - Yahoo! Finance Canada
Idexx Laboratories (IDXX) Launches Cancer Detection Panel in UK - GuruFocus
Three Seasons Wealth LLC Has $1.55 Million Stake in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Nisa Investment Advisors LLC Has $29.41 Million Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Announces UK Availability of Cancer Dx Panel for Early Detection of Canine Lymphoma - Business Wire
Can IDEXX Laboratories Inc sustain earnings growthMarket Sentiment Review & Capital Efficient Trading Techniques - baoquankhu1.vn
IDEXX Laboratories (NASDAQ:IDXX) Price Target Lowered to $675.00 at Stifel Nicolaus - MarketBeat
Stifel Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Cuts Target Price to $675 - 富途牛牛
Spire Wealth Management Boosts IDEXX Laboratories Stock Position - National Today
Spire Wealth Management Raises Stock Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX LABORATORIES INC (NASDAQ:IDXX) Passes the Caviar Cruise Quality Stock Screen - ChartMill
Companion Animal Health Market Forecast 2026-2033 Featuring Strategic Analysis of Agrolabo, Boehringer Ingelheim, Ceva, Elanco, IDEXX Labs and More - Yahoo Finance
IDEXX Laboratories, Inc. $IDXX Shares Acquired by Beacon Investment Advisory Services Inc. - MarketBeat
DAVENPORT & Co LLC Reduces IDEXX Laboratories Stake - National Today
DAVENPORT & Co LLC Sells 1,857 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDXX (IDEXX Laboratories) Net Issuance of Preferred Stock : $0 Mil (TTM As of Dec. 2025) - GuruFocus
IDEXX Laboratories Inc. stock underperforms Friday when compared to competitors - MarketWatch
[ARS] IDEXX LABORATORIES INC /DE SEC Filing - Stock Titan
IDEXX (NASDAQ: IDXX) proxy details 2025 growth, CEO change and key governance votes - Stock Titan
Vanguard disaggregates holdings; IDEXX (NASDAQ: IDXX) shows zero - Stock Titan
IDEXX Laboratories, Inc. $IDXX Shares Acquired by Global X Japan Co. Ltd. - MarketBeat
Riverbridge Partners LLC Sells 5,734 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
Tikehau Investment Management's IDEXX Laboratories Inc(IDXX) Holding History - GuruFocus
IDEXX Laboratories Announces Executive Departure and $984,000 Separation Agreement with Nimrata Hunt, PhD - Minichart
IDEXX Laboratories (IDXX) Announces Executive Transition with De - GuruFocus
Idexx Laboratories Announces Executive Departure Amid Strategic Realignment - TipRanks
Idexx Laboratories announces executive departure and separation agreement - investing.com
IDEXX: Nimrata Hunt to Leave EVP Role, Will Serve as Advisor Through July 13, 2026 - TradingView
IDEXX Laboratories (NASDAQ: IDXX) executive Nimrata Hunt plans exit with package - Stock Titan
IDEXX Laboratories Experiences Revision in Stock Evaluation Amid Strong Market Performance - Markets Mojo
Nordea Investment Management AB Boosts Stock Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
5-Star Stocks Poised to Pop: IDEXX Labs - Yahoo
IDXX (IDEXX Laboratories) Earnings Power Value (EPV) : $121.38 (As of Dec25) - GuruFocus
IDEXX Laboratories stock faces institutional shifts and insider sales amid strong FY2026 guidance - AD HOC NEWS
IDXX (IDEXX Laboratories) Cash Flow from Investing : $-136 Mil (TTM As of Dec. 2025) - GuruFocus
Portfolio Recap: Is IDEXX Laboratories Inc showing insider buyingQuarterly Profit Report & Accurate Buy Signal Alerts - baoquankhu1.vn
Here’s what analysts are saying about IDEXX Laboratories (IDXX) - MSN
IDEXX Laboratories, Inc. $IDXX Shares Acquired by Diversified Trust Co. - MarketBeat
Assenagon Asset Management S.A. Acquires 19,741 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
UBS reiterates Neutral rating on IDEXX Laboratories stock at $730 By Investing.com - Investing.com Canada
UBS Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Maintains Target Price $730 - 富途牛牛
Seilern Investment Management Ltd Decreases Stake in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Marshall Financial Group LLC Sells 1,936 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories, Inc. $IDXX Holdings Raised by Congress Asset Management Co. - MarketBeat
아이덱스 래버러토리스 (IDXX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.97%
1.23%
자본화:
|
볼륨(24시간):